Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josée Guindon

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Pharmacology & Physiology|March 28, 2012
Nabilone in inflammatory pain: to be or not to beJosée Guindon
Neuropharmacology|November 29, 2016
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependenceJosée Guindon
Neuropharmacology|January 31, 2006
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic painJosée Guindon, Pierre Beaulieu
Clinical and Experimental Pharmacology & Physiology|May 25, 2013
Muscarinic agonists in the treatment of neuropathic pain: a novel findingLiting Deng, Josée Guindon
Clinical and Experimental Pharmacology & Physiology|December 4, 2014
Inflammatory pain models with capsaicin or glutamate injections: are they comparable and reproducible?Josée Guindon, Jian-Sheng Lin
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Exploration of a novel therapeutic option: Use of a β<sub>2</sub> agonist to prevent neuropathic pain development secondary to spinal cord injury in a mouse modelRobert C Barnes, Josée Guindon
British Journal of Pharmacology|March 18, 2011
The endocannabinoid system and cancer: therapeutic implicationJosée Guindon, Andrea G Hohmann
CNS & Neurological Disorders Drug Targets|October 21, 2009
The endocannabinoid system and painJosée Guindon, Andrea G Hohmann
Neuroscience Letters|April 11, 2013
Use of sodium bicarbonate to promote weight gain, maintain body temperature, normalize renal functions and minimize mortality in rodents receiving the chemotherapeutic agent cisplatinJosée Guindon, Andrea G Hohmann
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2024
Special Section on Cannabinoid Signaling in Human Health and Disease-EditorialJosée Guindon, Daniel J Morgan
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Pharmacology & Physiology|March 28, 2012
Nabilone in inflammatory pain: to be or not to beJosée Guindon
Neuropharmacology|November 29, 2016
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependenceJosée Guindon
Neuropharmacology|January 31, 2006
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic painJosée Guindon, Pierre Beaulieu
Clinical and Experimental Pharmacology & Physiology|May 25, 2013
Muscarinic agonists in the treatment of neuropathic pain: a novel findingLiting Deng, Josée Guindon
Clinical and Experimental Pharmacology & Physiology|December 4, 2014
Inflammatory pain models with capsaicin or glutamate injections: are they comparable and reproducible?Josée Guindon, Jian-Sheng Lin
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Exploration of a novel therapeutic option: Use of a β<sub>2</sub> agonist to prevent neuropathic pain development secondary to spinal cord injury in a mouse modelRobert C Barnes, Josée Guindon
British Journal of Pharmacology|March 18, 2011
The endocannabinoid system and cancer: therapeutic implicationJosée Guindon, Andrea G Hohmann
CNS & Neurological Disorders Drug Targets|October 21, 2009
The endocannabinoid system and painJosée Guindon, Andrea G Hohmann
Neuroscience Letters|April 11, 2013
Use of sodium bicarbonate to promote weight gain, maintain body temperature, normalize renal functions and minimize mortality in rodents receiving the chemotherapeutic agent cisplatinJosée Guindon, Andrea G Hohmann
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2024
Special Section on Cannabinoid Signaling in Human Health and Disease-EditorialJosée Guindon, Daniel J Morgan
Pageof 5